Implantica (Sweden) Performance
| IMP-A-SDB | SEK 35.05 1.40 3.84% |
The company retains a Market Volatility (i.e., Beta) of -0.91, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Implantica are expected to decrease slowly. On the other hand, during market turmoil, Implantica is expected to outperform it slightly. At this point, Implantica AG has a negative expected return of -0.35%. Please make sure to check out Implantica's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if Implantica AG performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Implantica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Total Cashflows From Investing Activities | -51.6 M |
Implantica |
Implantica Relative Risk vs. Return Landscape
If you would invest 4,495 in Implantica AG on September 26, 2024 and sell it today you would lose (990.00) from holding Implantica AG or give up 22.02% of portfolio value over 90 days. Implantica AG is generating negative expected returns and assumes 2.7385% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Implantica, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Implantica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Implantica's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Implantica AG, and traders can use it to determine the average amount a Implantica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1283
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMP-A-SDB |
Estimated Market Risk
| 2.74 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Implantica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Implantica by adding Implantica to a well-diversified portfolio.
Implantica Fundamentals Growth
Implantica Stock prices reflect investors' perceptions of the future prospects and financial health of Implantica, and Implantica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Implantica Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0674 | |||
| Operating Margin | (24.51) % | |||
| Current Valuation | 5.38 B | |||
| Revenue | 707 K | |||
| EBITDA | (17.06 M) | |||
| Cash And Equivalents | 147.29 M | |||
| Cash Per Share | 2.12 X | |||
| Total Debt | 142 K | |||
| Book Value Per Share | 0.54 X | |||
| Cash Flow From Operations | (11.47 M) | |||
| Earnings Per Share | (0.06) X | |||
About Implantica Performance
Assessing Implantica's fundamental ratios provides investors with valuable insights into Implantica's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Implantica is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden.Things to note about Implantica AG performance evaluation
Checking the ongoing alerts about Implantica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Implantica AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Implantica AG generated a negative expected return over the last 90 days | |
| Implantica AG has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 707 K. Net Loss for the year was (15.36 M) with loss before overhead, payroll, taxes, and interest of (867 K). | |
| Implantica AG has accumulated about 147.29 M in cash with (11.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.12. |
- Analyzing Implantica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Implantica's stock is overvalued or undervalued compared to its peers.
- Examining Implantica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Implantica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Implantica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Implantica's stock. These opinions can provide insight into Implantica's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.